Reactions Weekly

, Volume 1125, Issue 1, pp 3–3 | Cite as

Antipsychotics: efficacy vs tolerability for AD symptoms

News item


Adverse Event Placebo Placebo Group Intervention Effectiveness Median Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA, CATIE-AD Study Group.Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine 355: 1525-1538, No. 15, 12 Oct 2006Google Scholar
  2. 2.
    Karlawish J.Alzheimer's disease - clinical trials and the logic of clinical purpose. New England Journal of Medicine 355: 1604-1606, No. 15, 12 Oct 2006Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2006

Personalised recommendations